Your browser doesn't support javascript.
loading
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Lo Re, Vincent; Zeldow, Bret; Kallan, Michael J; Tate, Janet P; Carbonari, Dena M; Hennessy, Sean; Kostman, Jay R; Lim, Joseph K; Goetz, Matthew Bidwell; Gross, Robert; Justice, Amy C; Roy, Jason A.
Afiliación
  • Lo Re V; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Zeldow B; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Kallan MJ; Medical Service, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
  • Tate JP; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Carbonari DM; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Hennessy S; VA Connecticut Healthcare System, West Haven, CT, USA.
  • Kostman JR; Yale University School of Medicine, New Haven, CT, USA.
  • Lim JK; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Goetz MB; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, and Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Gross R; Philadelphia Field Initiating Group for HIV Trials, John Bell Health Center, Philadelphia, PA, USA.
  • Justice AC; VA Connecticut Healthcare System, West Haven, CT, USA.
  • Roy JA; Yale University School of Medicine, New Haven, CT, USA.
Pharmacoepidemiol Drug Saf ; 26(10): 1172-1181, 2017 Oct.
Article en En | MEDLINE | ID: mdl-28722244
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fallo Hepático / Inhibidores de la Transcriptasa Inversa / Hepatitis C Crónica / Enfermedad Hepática Crónica Inducida por Sustancias y Drogas / Coinfección / Mitocondrias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Infecciones por VIH / Fallo Hepático / Inhibidores de la Transcriptasa Inversa / Hepatitis C Crónica / Enfermedad Hepática Crónica Inducida por Sustancias y Drogas / Coinfección / Mitocondrias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacoepidemiol Drug Saf Asunto de la revista: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2017 Tipo del documento: Article